Remove 2008 Remove Cannabinoids Remove DEA Remove Extraction
article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

International Cannabinoid Cancer Research Institute (Draft 5). However, there are indications from studies done with cannabidiol-rich cannabis extracts in Israel that indicate that less side effects (46%) are achieved with a natural cannabis plant extract containing a 20:1 ratio of CBD to THC. Research Director.

article thumbnail

Update on Industrial Hemp Legislation in California

Cannabis Law Report

In AB 228, the state, by declaring that food and cosmetics are not adulterated by the inclusion of hemp (including cannabinoids, extracts, or derivatives), essentially finds that hemp-derived products, including products containing CBD, are safe for human and animal consumption. DEA cases in the early 2000s.

Hemp 66
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What is THC? Here’s everything you need to know

The Cannigma

There are a lot of different molecules in nature, and though cannabinoids are rather rare, they are extremely abundant in cannabis (hence the name). THC is the most prevalent, famous and researched cannabinoid by far. What is THC? THC is short for tetrahydrocannabinol.

THC 98
article thumbnail

Treating Menstrual Cramps and PMDD with Medical Marijuana

MedicalJane

Using cannabis as a medicine is not a new practice, and recent research shows that cannabis extracts may represent an efficacious and safe alternative for treatment of a wide range of conditions in women including dysmenorrhea, dysuria, hyperemesis gravidarum, and menopausal symptoms. ” – Dr. Russo.

article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

It is worth noting that Marinol ® (dronabinol) is an FDA-approved synthetic cannabinoid that was placed in Schedule III under the CSA in 1999.). The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. 15, 2008 , 122 Stat. 2003, 2004, 2007, 2008, Nov. 262 , 270; Pub.

Banking 45